ASKA Biotech will be attending BIO-Europe in Cologne from November 9–11, 2026. Schedule a partnering meeting with Anke Holzinger to discuss customized CDMO solutions for mammalian cell expression, antibody development, and immunoassay scaling.
From November 9–11, 2026, the European life science community convenes in Cologne for BIO-Europe. ASKA Biotech is pleased to participate and connect with biotech innovators, diagnostic developers, and pharmaceutical partners.
As a specialized German CDMO, we partner with teams worldwide to bridge the gap between initial biomarker discovery and robust, reproducible production:
- Mammalian Biomanufacturing: Eukaryotic recombinant protein expression using CHO and HEK systems
- Antibody Development & Production: Monoclonal antibody generation and hybridoma cell culture
- Immunoassay & Kit Development: Custom ELISA engineering, assay transfer, and ISO 13485-certified manufacturing
Connect with us in Cologne:
Anke Holzinger (Managing Director – Business Development) will be on-site and available for one-on-one meetings.
Please request a meeting directly via the official PartneringONE platform or reach out by email at a.holzinger@aska-biotech.de to reserve a time slot. We look forward to exploring new synergies and discussing your pipeline requirements.
